Trial Site Detail
Drug: |
Imatinib + Sunitinib |
|||
|---|---|---|---|---|
Trial: |
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Vanderbilt-Ingram Cancer Center at Franklin2107 Edward Curd Ln |
Principal Investigator: |
Jordan Berlin |
|---|---|
Contact: |
615 343-4128 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Vanderbilt-Ingram Cancer Center at Franklin Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.